Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters

In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1998-05, Vol.349 (1), p.129-132
Hauptverfasser: Béı̈que, Jean-Claude, Lavoie, Normand, de Montigny, Claude, Debonnel, Guy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 132
container_issue 1
container_start_page 129
container_title European journal of pharmacology
container_volume 349
creator Béı̈que, Jean-Claude
Lavoie, Normand
de Montigny, Claude
Debonnel, Guy
description In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter ( K i=74 nM) and a very low affinity for the norepinephrine transporter ( K i=1.26 μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine binding sites.
doi_str_mv 10.1016/S0014-2999(98)00241-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80011193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299998002416</els_id><sourcerecordid>80011193</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qFWyBn4DkA6roIWWcxE58qhCiLRISB9qz5ThjrUvWTm3vCv493g_ttac5zPPOx0PIJYNvDJi4eQZgbVVLKa9l_xWgblklPpAF6ztZQcfqj2RxRE7J55T-AgCXNT8hJ1IIyUEsyMuttc677DDRYOkG_aStfnUeqfYj3ejowjrRiOs56xekzi_d4HKIidoQaV4iTRhDDt75XcKHiHOJz8u4HZKj9mkOMWNM5-ST1VPCi0M9I39-3P---1U9Pv18uLt9rEzLea7q1hroaxQAsufjgLwbcGibzrSD7i0CRxCNNOMoRd0IoTkMTTOylou662zfnJEv-7lzDP_WmLJauWRwmrTH8ozqixbGZFNAvgdNDClFtGqObqXjm2KgtpLVTrLaGlSyVzvJSpTc5WHBeljheEwdrJb-1aGvk9GTLQ6MS0esHN210BXs-x7DImPjMKpkHHqDo4toshqD-88h72ezmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80011193</pqid></control><display><type>article</type><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</creator><creatorcontrib>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</creatorcontrib><description>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter ( K i=74 nM) and a very low affinity for the norepinephrine transporter ( K i=1.26 μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine binding sites.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(98)00241-6</identifier><identifier>PMID: 9669506</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>5-HT (5-hydroxytryptamine, 5-HT) transporter ; Animals ; Antidepressant ; Antidepressive Agents, Second-Generation - metabolism ; Binding ; Binding, Competitive ; Biological and medical sciences ; Brain - metabolism ; Carrier Proteins - metabolism ; Cyclohexanols - metabolism ; Duloxetine ; Fluoxetine - analogs &amp; derivatives ; Fluoxetine - metabolism ; Imipramine - analogs &amp; derivatives ; Imipramine - metabolism ; Male ; Medical sciences ; Membrane Glycoproteins - metabolism ; Membrane Transport Proteins ; Nerve Tissue Proteins ; Neuropharmacology ; Neurotransmitter Uptake Inhibitors - metabolism ; Norepinephrine - antagonists &amp; inhibitors ; Norepinephrine - metabolism ; Norepinephrine Plasma Membrane Transport Proteins ; Norepinephrine transporter ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Radioligand Assay ; Rats ; Rats, Sprague-Dawley ; Serotonin - metabolism ; Serotonin Antagonists - metabolism ; Serotonin Plasma Membrane Transport Proteins ; Serotonin Uptake Inhibitors - metabolism ; Symporters ; Venlafaxine Hydrochloride</subject><ispartof>European journal of pharmacology, 1998-05, Vol.349 (1), p.129-132</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</citedby><cites>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0014-2999(98)00241-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2367407$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9669506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Béı̈que, Jean-Claude</creatorcontrib><creatorcontrib>Lavoie, Normand</creatorcontrib><creatorcontrib>de Montigny, Claude</creatorcontrib><creatorcontrib>Debonnel, Guy</creatorcontrib><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter ( K i=74 nM) and a very low affinity for the norepinephrine transporter ( K i=1.26 μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine binding sites.</description><subject>5-HT (5-hydroxytryptamine, 5-HT) transporter</subject><subject>Animals</subject><subject>Antidepressant</subject><subject>Antidepressive Agents, Second-Generation - metabolism</subject><subject>Binding</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Carrier Proteins - metabolism</subject><subject>Cyclohexanols - metabolism</subject><subject>Duloxetine</subject><subject>Fluoxetine - analogs &amp; derivatives</subject><subject>Fluoxetine - metabolism</subject><subject>Imipramine - analogs &amp; derivatives</subject><subject>Imipramine - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Membrane Transport Proteins</subject><subject>Nerve Tissue Proteins</subject><subject>Neuropharmacology</subject><subject>Neurotransmitter Uptake Inhibitors - metabolism</subject><subject>Norepinephrine - antagonists &amp; inhibitors</subject><subject>Norepinephrine - metabolism</subject><subject>Norepinephrine Plasma Membrane Transport Proteins</subject><subject>Norepinephrine transporter</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin - metabolism</subject><subject>Serotonin Antagonists - metabolism</subject><subject>Serotonin Plasma Membrane Transport Proteins</subject><subject>Serotonin Uptake Inhibitors - metabolism</subject><subject>Symporters</subject><subject>Venlafaxine Hydrochloride</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhq2qFWyBn4DkA6roIWWcxE58qhCiLRISB9qz5ThjrUvWTm3vCv493g_ttac5zPPOx0PIJYNvDJi4eQZgbVVLKa9l_xWgblklPpAF6ztZQcfqj2RxRE7J55T-AgCXNT8hJ1IIyUEsyMuttc677DDRYOkG_aStfnUeqfYj3ejowjrRiOs56xekzi_d4HKIidoQaV4iTRhDDt75XcKHiHOJz8u4HZKj9mkOMWNM5-ST1VPCi0M9I39-3P---1U9Pv18uLt9rEzLea7q1hroaxQAsufjgLwbcGibzrSD7i0CRxCNNOMoRd0IoTkMTTOylou662zfnJEv-7lzDP_WmLJauWRwmrTH8ozqixbGZFNAvgdNDClFtGqObqXjm2KgtpLVTrLaGlSyVzvJSpTc5WHBeljheEwdrJb-1aGvk9GTLQ6MS0esHN210BXs-x7DImPjMKpkHHqDo4toshqD-88h72ezmuA</recordid><startdate>19980515</startdate><enddate>19980515</enddate><creator>Béı̈que, Jean-Claude</creator><creator>Lavoie, Normand</creator><creator>de Montigny, Claude</creator><creator>Debonnel, Guy</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980515</creationdate><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><author>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>5-HT (5-hydroxytryptamine, 5-HT) transporter</topic><topic>Animals</topic><topic>Antidepressant</topic><topic>Antidepressive Agents, Second-Generation - metabolism</topic><topic>Binding</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Carrier Proteins - metabolism</topic><topic>Cyclohexanols - metabolism</topic><topic>Duloxetine</topic><topic>Fluoxetine - analogs &amp; derivatives</topic><topic>Fluoxetine - metabolism</topic><topic>Imipramine - analogs &amp; derivatives</topic><topic>Imipramine - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Membrane Transport Proteins</topic><topic>Nerve Tissue Proteins</topic><topic>Neuropharmacology</topic><topic>Neurotransmitter Uptake Inhibitors - metabolism</topic><topic>Norepinephrine - antagonists &amp; inhibitors</topic><topic>Norepinephrine - metabolism</topic><topic>Norepinephrine Plasma Membrane Transport Proteins</topic><topic>Norepinephrine transporter</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin - metabolism</topic><topic>Serotonin Antagonists - metabolism</topic><topic>Serotonin Plasma Membrane Transport Proteins</topic><topic>Serotonin Uptake Inhibitors - metabolism</topic><topic>Symporters</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Béı̈que, Jean-Claude</creatorcontrib><creatorcontrib>Lavoie, Normand</creatorcontrib><creatorcontrib>de Montigny, Claude</creatorcontrib><creatorcontrib>Debonnel, Guy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Béı̈que, Jean-Claude</au><au>Lavoie, Normand</au><au>de Montigny, Claude</au><au>Debonnel, Guy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1998-05-15</date><risdate>1998</risdate><volume>349</volume><issue>1</issue><spage>129</spage><epage>132</epage><pages>129-132</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter ( K i=74 nM) and a very low affinity for the norepinephrine transporter ( K i=1.26 μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine binding sites.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>9669506</pmid><doi>10.1016/S0014-2999(98)00241-6</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1998-05, Vol.349 (1), p.129-132
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_80011193
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 5-HT (5-hydroxytryptamine, 5-HT) transporter
Animals
Antidepressant
Antidepressive Agents, Second-Generation - metabolism
Binding
Binding, Competitive
Biological and medical sciences
Brain - metabolism
Carrier Proteins - metabolism
Cyclohexanols - metabolism
Duloxetine
Fluoxetine - analogs & derivatives
Fluoxetine - metabolism
Imipramine - analogs & derivatives
Imipramine - metabolism
Male
Medical sciences
Membrane Glycoproteins - metabolism
Membrane Transport Proteins
Nerve Tissue Proteins
Neuropharmacology
Neurotransmitter Uptake Inhibitors - metabolism
Norepinephrine - antagonists & inhibitors
Norepinephrine - metabolism
Norepinephrine Plasma Membrane Transport Proteins
Norepinephrine transporter
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Radioligand Assay
Rats
Rats, Sprague-Dawley
Serotonin - metabolism
Serotonin Antagonists - metabolism
Serotonin Plasma Membrane Transport Proteins
Serotonin Uptake Inhibitors - metabolism
Symporters
Venlafaxine Hydrochloride
title Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Affinities%20of%20venlafaxine%20and%20various%20reuptake%20inhibitors%20for%20the%20serotonin%20and%20norepinephrine%20transporters&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=B%C3%A9%C4%B1%CC%88que,%20Jean-Claude&rft.date=1998-05-15&rft.volume=349&rft.issue=1&rft.spage=129&rft.epage=132&rft.pages=129-132&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(98)00241-6&rft_dat=%3Cproquest_cross%3E80011193%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80011193&rft_id=info:pmid/9669506&rft_els_id=S0014299998002416&rfr_iscdi=true